|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
IL292038B2
(en)
|
2014-04-23 |
2024-12-01 |
Juno Therapeutics Inc |
Methods for enriching or producing immune cell populations for adoptive therapy
|
|
CN107429253B
(zh)
|
2014-12-05 |
2021-11-05 |
希望之城公司 |
Cs1靶向性嵌合抗原受体修饰的t细胞
|
|
EP3250602A1
(en)
|
2015-01-26 |
2017-12-06 |
Cellectis |
T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm
|
|
US12121539B2
(en)
|
2015-09-11 |
2024-10-22 |
Biosceptre (Aust) Pty Ltd |
Chimeric antigen receptors and uses thereof
|
|
US11090334B2
(en)
|
2016-01-29 |
2021-08-17 |
Med Manor Organics (P) Ltd. |
Chimeric antigen receptor specific to b-cell maturation antigen, a recombinant expression vector and a method thereof
|
|
SG10201912519VA
(en)
|
2016-04-01 |
2020-02-27 |
Kite Pharma Inc |
Chimeric receptors and methods of use thereof
|
|
KR102427334B1
(ko)
|
2016-04-01 |
2022-08-03 |
카이트 파마 인코포레이티드 |
키메라 항원 및 t 세포 수용체 및 사용 방법
|
|
NZ746700A
(en)
|
2016-04-01 |
2023-04-28 |
Kite Pharma Inc |
Bcma binding molecules and methods of use thereof
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
EP3478722A1
(en)
|
2016-06-30 |
2019-05-08 |
F. Hoffmann-La Roche AG |
Improved adoptive t-cell therapy
|
|
CN105949324B
(zh)
*
|
2016-06-30 |
2019-08-27 |
上海恒润达生生物科技有限公司 |
靶向gpc3的嵌合抗原受体及其用途
|
|
EP3518944A4
(en)
*
|
2016-09-30 |
2020-06-17 |
Baylor College of Medicine |
ADAPTIVE CHIMERIC ANTIGENT RECEPTOR T-CELL DESIGN
|
|
US12083148B2
(en)
|
2017-02-22 |
2024-09-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
IL13Ra2-binding chimeric antigen receptors
|
|
CN110582288B
(zh)
|
2017-02-28 |
2024-09-20 |
恩多塞特公司 |
用于car t细胞疗法的组合物和方法
|
|
WO2018169922A2
(en)
|
2017-03-13 |
2018-09-20 |
Kite Pharma, Inc. |
Chimeric antigen receptors for melanoma and uses thereof
|
|
WO2018175453A1
(en)
|
2017-03-20 |
2018-09-27 |
City Of Hope |
Cs1 targeted chimeric antigen receptor-modified t cells for treatment of al amyloidosis
|
|
CA3056837A1
(en)
|
2017-03-27 |
2018-10-04 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
BR102018008260A2
(pt)
|
2017-04-24 |
2020-04-28 |
Kite Pharma, Inc. |
domínios de ligação ao antígeno humanizado e métodos de uso
|
|
US11149073B2
(en)
|
2017-04-28 |
2021-10-19 |
Julius-Maximilians-Universität Würzburg |
ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains
|
|
WO2019025484A1
(en)
*
|
2017-08-01 |
2019-02-07 |
Julius-Maximilians-Universität Würzburg |
USE OF CAR-MODIFIED T LYMPHOCYTES FOR FLT3 AND FLT3 INHIBITORS FOR TREATING ACUTE MYELOID LEUKEMIA
|
|
US11950198B2
(en)
|
2017-08-11 |
2024-04-02 |
Interdigital Patent Holdings, Inc. |
Traffic steering and switching between multiple access networks
|
|
JP7357626B2
(ja)
*
|
2017-11-01 |
2023-10-06 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞の治療用組成物を生成するためのプロセス
|
|
US11464803B2
(en)
|
2017-11-14 |
2022-10-11 |
Arcellx, Inc. |
D-domain containing polypeptides and uses thereof
|
|
SI3710067T1
(sl)
*
|
2017-11-14 |
2026-01-30 |
Arcellx, Inc. |
Polipeptidi, ki vsebujejo D-domeno, in njihova uporaba
|
|
WO2019099707A1
(en)
|
2017-11-16 |
2019-05-23 |
Kite Pharma, Inc |
Modified chimeric antigen receptors and methods of use
|
|
CN119193493A
(zh)
|
2017-12-08 |
2024-12-27 |
朱诺治疗学股份有限公司 |
生产工程化t细胞组合物的过程
|
|
AU2018379091A1
(en)
|
2017-12-08 |
2020-06-25 |
Juno Therapeutics, Inc. |
Serum-free media formulation for culturing cells and methods of use thereof
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
CA3090793C
(en)
|
2018-02-16 |
2024-10-08 |
Kite Pharma, Inc. |
MODIFIED MULTIPOTENTED STEM CELLS, AND METHODS OF PREPARATION AND USE
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
AU2019275479B2
(en)
*
|
2018-05-21 |
2022-12-08 |
Biosceptre (Aust) Pty Ltd |
Chimeric antigen receptors with modified linker domains and uses thereof
|
|
WO2020009868A1
(en)
*
|
2018-07-03 |
2020-01-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-slamf7 chimeric antigen receptors
|
|
EP3830133A1
(en)
*
|
2018-08-01 |
2021-06-09 |
City of Hope |
Tag72 targeted chimeric antigen receptor modified t cells for treatment of tag72-positive tumors
|
|
CN112469734A
(zh)
*
|
2018-08-03 |
2021-03-09 |
南京驯鹿医疗技术有限公司 |
表达嵌合抗原受体的t细胞、该嵌合抗原相关表达载体以及它们的应用
|
|
BR112021002390A2
(pt)
|
2018-08-09 |
2021-05-11 |
Juno Therapeutics Inc |
processos para gerar células modificadas e suas composições
|
|
KR20250116790A
(ko)
|
2018-12-12 |
2025-08-01 |
카이트 파마 인코포레이티드 |
키메라 항원 수용체 및 car-t 세포 및 사용 방법
|
|
EP4332115A3
(en)
|
2019-04-03 |
2024-05-29 |
Precision Biosciences, Inc. |
Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
|
|
EP4549555A3
(en)
*
|
2019-05-24 |
2025-07-30 |
City of Hope |
Ccr4 targeted chimeric antigen receptor modified t cells for treatment of ccr4 positive malignancies
|
|
AU2020295715A1
(en)
*
|
2019-06-19 |
2022-02-17 |
Julius-Maximilians-Universität Würzburg |
Ultramodular IgG3-based spacer domain and multi-function site for implementation in chimeric antigen receptor design
|
|
CN112442126B
(zh)
*
|
2019-09-04 |
2022-07-29 |
杭州济元基因科技有限公司 |
一种抗人cs1抗原的单克隆抗体及其car-t细胞
|
|
JP2023525049A
(ja)
*
|
2020-05-08 |
2023-06-14 |
シアトル・チルドレンズ・ホスピタル・ドゥーイング／ビジネス／アズ・シアトル・チルドレンズ・リサーチ・インスティテュート |
ナチュラルキラー細胞を標的とするキメラ抗原受容体（ｃａｒ）
|
|
US12540336B2
(en)
|
2020-05-27 |
2026-02-03 |
The Medical College Of Wisconsin, Inc. |
Lentiviral vector transfer plasmid and methods of use
|
|
CN114286691B
(zh)
*
|
2020-08-06 |
2024-08-06 |
武汉思安医疗技术有限公司 |
Cs1-抗体和抗cs1-car-t细胞
|
|
JP7776493B2
(ja)
*
|
2020-08-10 |
2025-11-26 |
ユリウス－マクシミリアン－ウニヴェルシテート・ヴュルツブルク |
シグレック６結合ポリペプチド
|
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
|
JP2024514308A
(ja)
*
|
2021-03-30 |
2024-04-01 |
シティ・オブ・ホープ |
ＣＡＲ Ｔ細胞療法及びＩＦＮγ
|
|
CN117083292A
(zh)
*
|
2021-04-02 |
2023-11-17 |
科济生物医药（上海）有限公司 |
Cs1工程化细胞及其组合物
|
|
WO2023107898A1
(en)
*
|
2021-12-06 |
2023-06-15 |
The Children's Hospital Of Philadelphia |
Dual targeting of pediatric malignancies through car t-cells secreting bispecific innate immune cell engagers (bices)
|
|
CN116410331B
(zh)
*
|
2021-12-31 |
2024-01-30 |
合源生物科技(天津)有限公司 |
靶向cs1的嵌合抗原受体、靶向bcma/cs1的双特异性嵌合抗原受体及其应用
|
|
JP2025512797A
(ja)
*
|
2022-03-25 |
2025-04-22 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
改善されたキメラ受容体
|
|
EP4626924A4
(en)
*
|
2022-12-02 |
2026-07-15 |
Guangzhou Litai Biotechnology Co Ltd |
Human cs1 car-t cells
|
|
CN119019554B
(zh)
*
|
2023-05-25 |
2025-08-12 |
东莞市朋志生物科技有限公司 |
抗白介素6抗体、检测白介素6的试剂和试剂盒
|